Q2 2025 13F Holders as of 6/30/2025
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
87M
-
Number of holders
-
180
-
Total 13F shares, excl. options
-
82.2M
-
Shares change
-
+1.61M
-
Total reported value, excl. options
-
$474M
-
Value change
-
+$3.89M
-
Put/Call ratio
-
0.82
-
Number of buys
-
110
-
Number of sells
-
-72
-
Price
-
$5.77
Significant Holders of Kura Oncology, Inc. - Common Stock, par value $0.0001 per share (KURA) as of Q2 2025
214 filings reported holding KURA - Kura Oncology, Inc. - Common Stock, par value $0.0001 per share as of Q2 2025.
Kura Oncology, Inc. - Common Stock, par value $0.0001 per share (KURA) has 180 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 82.2M shares
of 87M outstanding shares and own 94.44% of the company stock.
Largest 10 shareholders include BlackRock, Inc. (9.47M shares), SUVRETTA CAPITAL MANAGEMENT, LLC (8.12M shares), BVF INC/IL (7.75M shares), ARMISTICE CAPITAL, LLC (6.2M shares), VANGUARD GROUP INC (5.35M shares), EcoR1 Capital, LLC (4.2M shares), Prosight Management, LP (3.18M shares), STATE STREET CORP (3.04M shares), MILLENNIUM MANAGEMENT LLC (2.62M shares), and GEODE CAPITAL MANAGEMENT, LLC (2.01M shares).
This table shows the top 180 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.